Research ArticleDrug Discovery and Translational Medicine
Clinically Relevant Doses of Candesartan Inhibit Growth of Prostate Tumor Xenografts In Vivo through Modulation of Tumor Angiogenesis
Ahmed Alhusban, Ahmad Al-Azayzih, Anna Goc, Fei Gao, Susan C. Fagan and Payaningal R. Somanath
Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 635-645; DOI: https://doi.org/10.1124/jpet.114.216382
Ahmed Alhusban
Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy and the Charlie Norwood VA Medical Center, Augusta, Georgia (A.A., A.A.-A., A.G., F.G., S.C.F., P.R.S.); Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan (A.A.); and Departments of Neurology (S.C.F.), Medicine (P.R.S.), Cancer Center (P.R.S.), and Vascular Biology Center (P.R.S.), Georgia Regents University, Augusta, Georgia
Ahmad Al-Azayzih
Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy and the Charlie Norwood VA Medical Center, Augusta, Georgia (A.A., A.A.-A., A.G., F.G., S.C.F., P.R.S.); Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan (A.A.); and Departments of Neurology (S.C.F.), Medicine (P.R.S.), Cancer Center (P.R.S.), and Vascular Biology Center (P.R.S.), Georgia Regents University, Augusta, Georgia
Anna Goc
Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy and the Charlie Norwood VA Medical Center, Augusta, Georgia (A.A., A.A.-A., A.G., F.G., S.C.F., P.R.S.); Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan (A.A.); and Departments of Neurology (S.C.F.), Medicine (P.R.S.), Cancer Center (P.R.S.), and Vascular Biology Center (P.R.S.), Georgia Regents University, Augusta, Georgia
Fei Gao
Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy and the Charlie Norwood VA Medical Center, Augusta, Georgia (A.A., A.A.-A., A.G., F.G., S.C.F., P.R.S.); Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan (A.A.); and Departments of Neurology (S.C.F.), Medicine (P.R.S.), Cancer Center (P.R.S.), and Vascular Biology Center (P.R.S.), Georgia Regents University, Augusta, Georgia
Susan C. Fagan
Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy and the Charlie Norwood VA Medical Center, Augusta, Georgia (A.A., A.A.-A., A.G., F.G., S.C.F., P.R.S.); Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan (A.A.); and Departments of Neurology (S.C.F.), Medicine (P.R.S.), Cancer Center (P.R.S.), and Vascular Biology Center (P.R.S.), Georgia Regents University, Augusta, Georgia
Payaningal R. Somanath
Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy and the Charlie Norwood VA Medical Center, Augusta, Georgia (A.A., A.A.-A., A.G., F.G., S.C.F., P.R.S.); Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan (A.A.); and Departments of Neurology (S.C.F.), Medicine (P.R.S.), Cancer Center (P.R.S.), and Vascular Biology Center (P.R.S.), Georgia Regents University, Augusta, Georgia
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleDrug Discovery and Translational Medicine
Candesartan and Prostate Cancer
Ahmed Alhusban, Ahmad Al-Azayzih, Anna Goc, Fei Gao, Susan C. Fagan and Payaningal R. Somanath
Journal of Pharmacology and Experimental Therapeutics September 1, 2014, 350 (3) 635-645; DOI: https://doi.org/10.1124/jpet.114.216382
Research ArticleDrug Discovery and Translational Medicine
Candesartan and Prostate Cancer
Ahmed Alhusban, Ahmad Al-Azayzih, Anna Goc, Fei Gao, Susan C. Fagan and Payaningal R. Somanath
Journal of Pharmacology and Experimental Therapeutics September 1, 2014, 350 (3) 635-645; DOI: https://doi.org/10.1124/jpet.114.216382
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement